Literature DB >> 2742753

Properties of sialidase isolated from Actinomyces viscosus DSM 43798.

M Teufel1, P Roggentin, R Schauer.   

Abstract

The cell-bound sialidase of Actinomyces viscosus DSM 43798 was solubilized by mechanical cell disruption and lysozyme treatment. The enzyme was enriched 30,000-fold by cation-exchange chromatography, gel-filtration, and FPLC ion-exchange chromatography, thus obtaining 10 micrograms sialidase protein from 26 g wet cells with a specific activity of 680 U/mg protein. Since sialidase activity was also found in the culture medium, this enzyme was isolated as well, requiring the additional application of FPLC gel-filtration. Both sialidase preparations were apparently homogenous on SDS-PAGE and have similar properties. The substrate specificity of the A. viscosus sialidase was tested with 16 sialoglycoconjugates: The enzyme showed a higher activity with serum glycoproteins than with gangliosides, mucins or sialyllactoses. 4-O-Acetylated N-acetylneuraminic acid was not cleaved from equine submandibular gland mucins or serum glycoproteins in contrast to N-acetyl- and N-glycoloylneuraminic acid. 9-O-Acetyl-N-acetylneuraminic acid was released from bovine submandibular gland mucin, as confirmed by TLC. The sialidase hydrolyses alpha(2----6)-linkages more rapidly than alpha(2----8)- and alpha(2----3)-bonds. Cations, except Hg2+, or chelating agents have no influence on enzyme activity. The sialidase has a relatively high molecular mass of 150 kDa, but consists of only one unit. The enzyme is labile towards freezing and thawing, but can be stored at 4 degrees C in 0.1 M acetate buffer, pH 5.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742753     DOI: 10.1515/bchm3.1989.370.1.435

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  9 in total

1.  The sialidase gene from Clostridium septicum: cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins.

Authors:  B Rothe; B Rothe; P Roggentin; R Schauer
Journal:  Mol Gen Genet       Date:  1991-04

2.  Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

Authors:  Michael P Malakhov; Laura M Aschenbrenner; Donald F Smee; Miles K Wandersee; Robert W Sidwell; Larisa V Gubareva; Vasiliy P Mishin; Frederick G Hayden; Do Hyong Kim; Alice Ing; Erin R Campbell; Mang Yu; Fang Fang
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  DAS181 inhibits H5N1 influenza virus infection of human lung tissues.

Authors:  Renee W Y Chan; Michael C W Chan; Adam C N Wong; Rositsa Karamanska; Anne Dell; Stuart M Haslam; Alan D L Sihoe; W H Chui; Gallen Triana-Baltzer; Qixiang Li; J S Malik Peiris; Fang Fang; John M Nicholls
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

4.  Isolation of a neuraminidase gene from Actinomyces viscosus T14V.

Authors:  M K Yeung; S R Fernandez
Journal:  Appl Environ Microbiol       Date:  1991-11       Impact factor: 4.792

5.  Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins.

Authors:  A Scharfman; R Ramphal; C Neut; C Carnoy; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Purification and characterization of a sialidase from Clostridium chauvoei NC08596.

Authors:  D Heuermann; P Roggentin; R G Kleineidam; R Schauer
Journal:  Glycoconj J       Date:  1991-04       Impact factor: 2.916

7.  Intrinsic carnosine metabolism in the human kidney.

Authors:  Verena Peters; Celine Q F Klessens; Hans J Baelde; Benjamin Singler; Kimberley A M Veraar; Ana Zutinic; Jakub Drozak; Johannes Zschocke; Claus P Schmitt; Emile de Heer
Journal:  Amino Acids       Date:  2015-07-24       Impact factor: 3.520

8.  Evaluation of the potential defensive strategy against Influenza A in cell line models.

Authors:  Ekaterina Antonova; Olga Glazova; Anna Gaponova; Aykaz Eremyan; Natalya Grebenkina; Svetlana Zvereva; Natalya Volkova; Pavel Volchkov
Journal:  F1000Res       Date:  2018-02-19

Review 9.  The use of sialidase therapy for respiratory viral infections.

Authors:  John M Nicholls; Ronald B Moss; Stuart M Haslam
Journal:  Antiviral Res       Date:  2013-04-17       Impact factor: 5.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.